<SEC-DOCUMENT>0001104659-16-105686-index.html : 20160317
<SEC-HEADER>0001104659-16-105686.hdr.sgml : 20160317
<ACCEPTANCE-DATETIME>20160317073813
ACCESSION NUMBER:		0001104659-16-105686
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20151231
FILED AS OF DATE:		20160317
DATE AS OF CHANGE:		20160317

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adaptimmune Therapeutics PLC
		CENTRAL INDEX KEY:			0001621227
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37368
		FILM NUMBER:		161511247

	BUSINESS ADDRESS:	
		STREET 1:		101 PARK DRIVE
		STREET 2:		MILTON PARK
		CITY:			ABINGDON, OXFORDSHIRE
		STATE:			X0
		ZIP:			OX14 4RY
		BUSINESS PHONE:		44 1235 430000

	MAIL ADDRESS:	
		STREET 1:		101 PARK DRIVE
		STREET 2:		MILTON PARK
		CITY:			ABINGDON, OXFORDSHIRE
		STATE:			X0
		ZIP:			OX14 4RY

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adaptimmune Ltd
		DATE OF NAME CHANGE:	20141001
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>a16-5330_120f.htm
<DESCRIPTION>20-F
<TEXT>
Document 1 - file: a16-5330_120f.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>2
<FILENAME>a16-5330_1ex4d3.htm
<DESCRIPTION>EX-4.3
<TEXT>
Document 2 - file: a16-5330_1ex4d3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>3
<FILENAME>a16-5330_1ex4d4.htm
<DESCRIPTION>EX-4.4
<TEXT>
Document 3 - file: a16-5330_1ex4d4.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.28
<SEQUENCE>4
<FILENAME>a16-5330_1ex4d28.htm
<DESCRIPTION>EX-4.28
<TEXT>
Document 4 - file: a16-5330_1ex4d28.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.29
<SEQUENCE>5
<FILENAME>a16-5330_1ex4d29.htm
<DESCRIPTION>EX-4.29
<TEXT>
Document 5 - file: a16-5330_1ex4d29.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.30
<SEQUENCE>6
<FILENAME>a16-5330_1ex4d30.htm
<DESCRIPTION>EX-4.30
<TEXT>
Document 6 - file: a16-5330_1ex4d30.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.31
<SEQUENCE>7
<FILENAME>a16-5330_1ex4d31.htm
<DESCRIPTION>EX-4.31
<TEXT>
Document 7 - file: a16-5330_1ex4d31.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.32
<SEQUENCE>8
<FILENAME>a16-5330_1ex4d32.htm
<DESCRIPTION>EX-4.32
<TEXT>
Document 8 - file: a16-5330_1ex4d32.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.33
<SEQUENCE>9
<FILENAME>a16-5330_1ex4d33.htm
<DESCRIPTION>EX-4.33
<TEXT>
Document 9 - file: a16-5330_1ex4d33.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.34
<SEQUENCE>10
<FILENAME>a16-5330_1ex4d34.htm
<DESCRIPTION>EX-4.34
<TEXT>
Document 10 - file: a16-5330_1ex4d34.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.35
<SEQUENCE>11
<FILENAME>a16-5330_1ex4d35.htm
<DESCRIPTION>EX-4.35
<TEXT>
Document 11 - file: a16-5330_1ex4d35.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.36
<SEQUENCE>12
<FILENAME>a16-5330_1ex4d36.htm
<DESCRIPTION>EX-4.36
<TEXT>
Document 12 - file: a16-5330_1ex4d36.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>13
<FILENAME>a16-5330_1ex12d1.htm
<DESCRIPTION>EX-12.1
<TEXT>
Document 13 - file: a16-5330_1ex12d1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>14
<FILENAME>a16-5330_1ex12d2.htm
<DESCRIPTION>EX-12.2
<TEXT>
Document 14 - file: a16-5330_1ex12d2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>15
<FILENAME>a16-5330_1ex13d1.htm
<DESCRIPTION>EX-13.1
<TEXT>
Document 15 - file: a16-5330_1ex13d1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>16
<FILENAME>a16-5330_1ex13d2.htm
<DESCRIPTION>EX-13.2
<TEXT>
Document 16 - file: a16-5330_1ex13d2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.1
<SEQUENCE>17
<FILENAME>a16-5330_1ex15d1.htm
<DESCRIPTION>EX-15.1
<TEXT>
Document 17 - file: a16-5330_1ex15d1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g53301kg01i001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
Document 18 - file: g53301kg01i001.gif

</DOCUMENT>
</SEC-DOCUMENT>